Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer
30/06/2025 12:23
June 30 (Reuters) - Oncolytics Biotech Inc ONC.TO: ONCOLYTICS BIOTECH® APPOINTS FORMER AMBRX EXECUTIVE AS CHIEF BUSINESS OFFICER TO DRIVE BUSINESS DEVELOPMENT STRATEGY Source text: ID:nCNW45Vp7a Further company coverage: ONC.TO (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer